Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020

NEXT STORY
Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer
PREV STORY
CohBar Reports Third Quarter 2020 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx Announces Appointment of Maged Shenouda as Chief Financial Officer

NEW YORK, Sept. 25, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

author_avatar
NASDAQ Market News

Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn’s disease patients

PRESS RELEASE Takeda and TiGenix announce that Swissmedic has accepted for review the file ...

author_avatar
NASDAQ Market News

Global qPCR and dPCR Instrumentation Market Report 2021: U.S. Market is Estimated at $1.9 Billion in 2021, While China is Forecast to Reach $742.3 Million by 2026

author_avatar
NASDAQ Market News